Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study.

IF 8.3 2区 材料科学 Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY
ACS Applied Materials & Interfaces Pub Date : 2024-10-18 eCollection Date: 2024-01-01 DOI:10.3389/fimmu.2024.1461407
P Triggianese, R Senter, F Perego, A Gidaro, A Petraroli, F Arcoleo, L Brussino, F Giardino, O Rossi, D Bignardi, P Quattrocchi, R Brancaccio, A Cesoni Marcelli, P A Accardo, L Lo Sardo, E Cataudella, M D Guarino, D Firinu, A Bergamini, G Spadaro, A Zanichelli, M Cancian
{"title":"Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study.","authors":"P Triggianese, R Senter, F Perego, A Gidaro, A Petraroli, F Arcoleo, L Brussino, F Giardino, O Rossi, D Bignardi, P Quattrocchi, R Brancaccio, A Cesoni Marcelli, P A Accardo, L Lo Sardo, E Cataudella, M D Guarino, D Firinu, A Bergamini, G Spadaro, A Zanichelli, M Cancian","doi":"10.3389/fimmu.2024.1461407","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In patients with Hereditary Angioedema (HAE) related to primary C1 inhibitor deficiency (C1INH), the defective clearance of immune complexes and apoptotic materials along with impairment of normal humoral response potentially leads to autoimmunity. Few studies report evidence on autoimmune diseases in C1INH-HAE, but no large population studies focus on rare connective tissue diseases (RCTDs). We aim at evaluating for the first time prevalence and distribution of RCTDs - Systemic Lupus Erytematosus (SLE), primary Sjogren Syndrome (SjS), primary antiphospholipid syndrome (APS), Systemic Sclerosis (SSc), and mixed connective tissue diseases (MCTD) in a large Italian cohort of C1INH-HAE patients.</p><p><strong>Methods: </strong>A multicenter observational study includes C1INH-HAE patients from ITACA Centers throughout Italy (time frame Sept 2023-March 2024). Inclusion criteria are i. a defined diagnosis of type I or type II C1INH-HAE; ii. age ≥15 years (puberty already occurred); iii. enrollment in the ITACA Registry. The diagnosis of SLE, primary SjS, primary APS, SSc, and MCTD are made in accordance with international classification criteria.</p><p><strong>Results: </strong>Data are collected from a total of 855 C1INH-HAE patients referring to 15 ITACA Centers. Patients with concomitant RCTDs were 18/855 (2.1%) with F:M ratio 3.5 and a prevalent type I C1INH-HAE diagnosis (87.2%). A diagnosis of SLE results in 44.5% of cases (n=8) while the remaining diagnoses are primary SjS (22.2%, n=4), primary APS (16.6%, n=3), SSc (11.2%, n=2), and a single case of MCTD (5.5%). The female gender is prevalent in all the RCTDs. Patients on long term prophylaxis (LTP) are significantly prevalent in RCTDs group than in the whole C1INH-HAE population (p<0.01).</p><p><strong>Conclusions: </strong>A relevant prevalence of RCTDs is documented in C1INH-HAE patients, mainly SLE. Patients with RCTDs are on LTP in a significant proportion supporting the idea of a bidirectional link between C1INH-HAE and autoimmunity.</p>","PeriodicalId":5,"journal":{"name":"ACS Applied Materials & Interfaces","volume":null,"pages":null},"PeriodicalIF":8.3000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527674/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Materials & Interfaces","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2024.1461407","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In patients with Hereditary Angioedema (HAE) related to primary C1 inhibitor deficiency (C1INH), the defective clearance of immune complexes and apoptotic materials along with impairment of normal humoral response potentially leads to autoimmunity. Few studies report evidence on autoimmune diseases in C1INH-HAE, but no large population studies focus on rare connective tissue diseases (RCTDs). We aim at evaluating for the first time prevalence and distribution of RCTDs - Systemic Lupus Erytematosus (SLE), primary Sjogren Syndrome (SjS), primary antiphospholipid syndrome (APS), Systemic Sclerosis (SSc), and mixed connective tissue diseases (MCTD) in a large Italian cohort of C1INH-HAE patients.

Methods: A multicenter observational study includes C1INH-HAE patients from ITACA Centers throughout Italy (time frame Sept 2023-March 2024). Inclusion criteria are i. a defined diagnosis of type I or type II C1INH-HAE; ii. age ≥15 years (puberty already occurred); iii. enrollment in the ITACA Registry. The diagnosis of SLE, primary SjS, primary APS, SSc, and MCTD are made in accordance with international classification criteria.

Results: Data are collected from a total of 855 C1INH-HAE patients referring to 15 ITACA Centers. Patients with concomitant RCTDs were 18/855 (2.1%) with F:M ratio 3.5 and a prevalent type I C1INH-HAE diagnosis (87.2%). A diagnosis of SLE results in 44.5% of cases (n=8) while the remaining diagnoses are primary SjS (22.2%, n=4), primary APS (16.6%, n=3), SSc (11.2%, n=2), and a single case of MCTD (5.5%). The female gender is prevalent in all the RCTDs. Patients on long term prophylaxis (LTP) are significantly prevalent in RCTDs group than in the whole C1INH-HAE population (p<0.01).

Conclusions: A relevant prevalence of RCTDs is documented in C1INH-HAE patients, mainly SLE. Patients with RCTDs are on LTP in a significant proportion supporting the idea of a bidirectional link between C1INH-HAE and autoimmunity.

C1抑制剂缺乏性遗传性血管性水肿患者中的罕见结缔组织疾病:一项大型意大利队列研究提供的有关发病率和分布情况的第一手证据。
简介:在与原发性 C1 抑制剂缺乏症(C1INH)有关的遗传性血管性水肿(HAE)患者中,免疫复合物和凋亡物质的清除缺陷以及正常体液反应的损害可能会导致自身免疫。很少有研究报告了 C1INH-HAE 患者自身免疫性疾病的证据,但没有大规模人群研究关注罕见结缔组织病(RCTD)。我们的目的是首次评估意大利大型 C1INH-HAE 患者队列中 RCTD(系统性红斑狼疮(SLE)、原发性 Sjogren 综合征(SjS)、原发性抗磷脂综合征(APS)、系统性硬化症(SSc)和混合性结缔组织病(MCTD))的患病率和分布情况:多中心观察研究包括来自意大利各地 ITACA 中心的 C1INH-HAE 患者(时间范围为 2023 年 9 月至 2024 年 3 月)。纳入标准为:i. 确诊为 I 型或 II 型 C1INH-HAE;ii. 年龄≥15 岁(已进入青春期);iii. 在 ITACA 登记处注册。系统性红斑狼疮、原发性 SjS、原发性 APS、SSc 和 MCTD 的诊断依据国际分类标准:结果:共收集到 15 个 ITACA 中心转诊的 855 名 C1INH-HAE 患者的数据。其中18/855(2.1%)例患者同时患有RCTD,男女比例为3.5,诊断为I型C1INH-HAE的患者占87.2%。44.5%的病例诊断为系统性红斑狼疮(8 例),其余诊断为原发性 SjS(22.2%,4 例)、原发性 APS(16.6%,3 例)、SSc(11.2%,2 例)和一例 MCTD(5.5%)。所有 RCTD 患者均为女性。接受长期预防治疗(LTP)的患者在 RCTDs 组中的发病率明显高于整个 C1INH-HAE 群体(p结论:在C1INH-HAE患者(主要是系统性红斑狼疮患者)中,RCTD的发病率很高。RCTD患者中有很大一部分在服用LTP,这支持了C1INH-HAE与自身免疫之间存在双向联系的观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Materials & Interfaces
ACS Applied Materials & Interfaces 工程技术-材料科学:综合
CiteScore
16.00
自引率
6.30%
发文量
4978
审稿时长
1.8 months
期刊介绍: ACS Applied Materials & Interfaces is a leading interdisciplinary journal that brings together chemists, engineers, physicists, and biologists to explore the development and utilization of newly-discovered materials and interfacial processes for specific applications. Our journal has experienced remarkable growth since its establishment in 2009, both in terms of the number of articles published and the impact of the research showcased. We are proud to foster a truly global community, with the majority of published articles originating from outside the United States, reflecting the rapid growth of applied research worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信